Polar Asset Management Partners Inc. Invitae Corp Transaction History

Polar Asset Management Partners Inc.

  • $4.57 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.9 - $8.63 $3.21 Million - $14.6 Million
1,690,235 New
1,690,235 $4.16 Million
Q3 2019

Nov 14, 2019
SELL
$18.85 - $27.5 $6.13 Million - $8.94 Million
-325,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$17.37 - $26.27 $5.65 Million - $8.54 Million
325,000 New
325,000 $7.64 Million

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email